Categories: AirlinesAll posts

Don’t bet the farm on Air Canada stock, this portfolio manager says

Over the past few years, Air Canada (Air Canada Stock Quote, Chart TSX:AC) has done a bang-up job in turning its business around and the results are now showing in its share price, which is hitting new highs. While there could still be more upside to the stock, says Bruce Murray of The Murray Wealth Group, taking a half position is probably the wisest choice.

Air Canada is up one per cent in midday trading on Tuesday as the stock continues to climb and now sits up 23 per cent year-to-date. Ahead of the company’s quarterly report on Friday, investors are hoping for more good news from management about its ability to control costs where it can, despite the ups and downs in the price of oil.

In late October of last year, AC’s share price rose on the release of the company’s third quarter financials, which while featuring a 63 per cent year-over-year drop in net income due to higher fuel costs nonetheless showed a 3.4 per cent growth in passenger revenue per mile.

With its Q3 report, Air Canada President and CEO Calin Rovinescu underlined his company’s focus on reducing costs, saying, “I am extremely pleased with both our unit revenue performance and our adjusted [cost per available seat mile] results for our all-important third quarter. Strong revenue and cost management substantially offset the challenges we faced in the quarter, principally the significant increase in fuel prices.”

It’s that tiptop form that’s rightly garnering praise for AC, says Murray.

“When I entered the business of railroad stocks, everybody hated to invest in them because they were badly run, they had union problems. Then in the 1990s they got cleaned up and became great investments. The airlines are going through the tag end of that process,” says Murray, CEO of The Murray Wealth Group, in conversation with BNN Bloomberg on Monday.

“The big governments are out of the airlines, the unions are onside now with what’s going on in the businesses,” he says. “We own Air Canada and we like it. When you do the financial work, there’s so much leverage that the stock could go substantially higher.”

“But it is an airline stock so it’s subject to all kinds of rumours, volatility, the price of gas, so I wouldn’t purchase a full position,” Murray says. “I would buy some and if it pulls back on anything, buy it then. If it keeps going up, you’ve got a little bit.”

“I’ve seen targets well into the $40s, but the big part of the run is over,” he says.

Tagged with: ac
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Hammond Power Solutions: this analyst just raised his price target

Paradigm Capital analyst Razi Hasan raised his target on Hammond Power Solutions (Hammond Power Solutions Stock Quote, Chart, News, Analysts,… [Read More]

1 hour ago

This analyst just slashed his price target on ProMIS Neurosciences

Roth Capital Partners analyst Boobalan Pachaiyappan cut his target on ProMIS Neurosciences (ProMIS Neurosciences Stock Quote, Chart, News, Analysts, Financials… [Read More]

2 hours ago

First Solar stock: Buy, Sell or Hold?

Roth Capital Partners analyst Philip Shen maintained his “Buy” rating and US$300.00 target on First Solar (First Solar, Stock Quote,… [Read More]

3 hours ago

Hut 8 stock: Buy, Sell or Hold?

Roth Capital Partners analyst Bryan Baratian maintained his “Buy” rating and US$108.00 target on Hut 8 (Hut 8 Stock Quote,… [Read More]

20 hours ago

This investor explains why he loves Topicus stock

Baskin Wealth Management president and chief investment officer Barry Schwartz named Topicus.com (Topicus.com Stock Quote, Chart, News, Analysts, Financials TSX:TOI)… [Read More]

20 hours ago

RNA stock: time to buy?

On Oct. 29 Roth Capital Partners analyst Boobalan Pachaiyappan maintained his “Buy” rating and US$15.00 target on Atrium Therapeutics (Atrium… [Read More]

20 hours ago